Literature DB >> 30574499

The Susceptibility Genes in Diabetic Nephropathy.

Ling Wei1, Ying Xiao1, Li Li1, Xiaofen Xiong1, Yachun Han1, Xuejing Zhu1, Lin Sun1.   

Abstract

BACKGROUND: Diabetes mellitus (DM) poses a severe threat to global public health. Diabetic nephropathy (DN) is one of the most common complications of diabetes and the leading cause of end-stage renal disease (ESRD). Approximately 30-40% of DM patients in the world progress to ESRD, which emphasizes the effect of genetic factors on DN. Family clustering also supports the important role of hereditary factors in DN and ESRD. Therefore, a large number of genetic studies have been carried out to identify susceptibility genes in different diabetic cohorts. Extensive susceptibility genes of DN and ESRD have not been identified until recently. SUMMARY AND KEY MESSAGES: Some of these associated genes function as pivotal regulators in the pathogenesis of DN, such as those related to glycometabolism and lipid metabolism. However, the functions of most of these genes remain unclear. In this article, we review several susceptibility genes according to their genetic functions to make it easier to determine their exact effect on DN and to provide a better understanding of the advancements from genetic studies. However, several challenges associated with investigating the genetic factors of DN still exist. For instance, it is difficult to determine whether these variants affect the expression of the protein they encode or other cytokines. More efforts should be made to determine how these genes influence the progression of DN. In addition, many results could not be replicated among races, suggesting that the association between genetic polymorphisms and DN is race-specific. Therefore, large, well-designed studies involving more relevant variables and ethnic groups and more relevant functional studies are urgently needed. These studies may be beneficial and retard the progression of DN by early intervention, especially for patients who carry certain risk alleles or genotypes.

Entities:  

Keywords:  Diabetic nephropathy; End-stage renal disease; Gene polymorphism; Genetic studies; Single nucleotide polymorphism; Susceptibility genes

Year:  2018        PMID: 30574499      PMCID: PMC6276750          DOI: 10.1159/000492633

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  81 in total

1.  Structure of a human Tcf4-beta-catenin complex.

Authors:  F Poy; M Lepourcelet; R A Shivdasani; M J Eck
Journal:  Nat Struct Biol       Date:  2001-12

2.  Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.

Authors:  Atsuyuki Shimazaki; Yoshihiro Kawamura; Akio Kanazawa; Akihiro Sekine; Susumu Saito; Tatsuhiko Tsunoda; Daisuke Koya; Tetsuya Babazono; Yasushi Tanaka; Masafumi Matsuda; Koichi Kawai; Tomohiro Iiizumi; Masahito Imanishi; Toshihiro Shinosaki; Toru Yanagimoto; Minoru Ikeda; Shigeki Omachi; Atsunori Kashiwagi; Kohei Kaku; Yasuhiko Iwamoto; Ryuzou Kawamori; Ryuichi Kikkawa; Masatoshi Nakajima; Yusuke Nakamura; Shiro Maeda
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

3.  Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study.

Authors:  Andrew P Boright; Andrew D Paterson; Lucia Mirea; Shelley B Bull; Alireza Mowjoodi; Stephen W Scherer; Bernard Zinman
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

4.  SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy.

Authors:  Jae Hyeon Kim; Hyoung Doo Shin; Byung Lae Park; Min Kyong Moon; Young Min Cho; Young Hwan Hwang; Kook Whan Oh; Seong Yeon Kim; Hong Kyu Lee; Curie Ahn; Kyong Soo Park
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

5.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Authors:  Steen Andersen; Lise Tarnow; Francois Cambien; Peter Rossing; Tina R Juhl; Jaap Deinum; Hans-Henrik Parving
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

7.  Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study.

Authors:  K Nishiyama; Y Tanaka; K Nakajima; A Mokubo; Y Atsumi; K Matsuoka; H Watada; T Hirose; T Nomiyama; S Maeda; R Kawamori
Journal:  Diabetologia       Date:  2005-05-25       Impact factor: 10.122

8.  Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.

Authors:  L Abu-Elheiga; M M Matzuk; K A Abo-Hashema; S J Wakil
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

9.  BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module.

Authors:  Daeho Park; Annie-Carole Tosello-Trampont; Michael R Elliott; Mingjian Lu; Lisa B Haney; Zhong Ma; Alexander L Klibanov; James W Mandell; Kodi S Ravichandran
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

10.  Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.

Authors:  Bingmei Yang; Deborah F Cross; Martin Ollerenshaw; Beverly A Millward; Andrew G Demaine
Journal:  J Diabetes Complications       Date:  2003 Jan-Feb       Impact factor: 2.852

View more
  11 in total

1.  Association between engulfment and cell motility 1-gene polymorphisms and diabetic nephropathy in an Egyptian population with type 2 diabetes.

Authors:  Maggie S El Nahid; Amal Fouad Mohamed Al-Ganiny; Rasha Nazih Youssef
Journal:  J Diabetes Metab Disord       Date:  2022-02-10

2.  The Human Genetic Variants CYP2J2 rs2280275 and EPHX2 rs751141 and Risk of Diabetic Nephropathy in Egyptian Type 2 Diabetic Patients.

Authors:  Mona S Habieb; Ashraf A Dawood; Mahmoud M Emara; Mohammad G Elhelbawy; Nesreen G Elhelbawy
Journal:  Appl Clin Genet       Date:  2020-11-19

3.  ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.

Authors:  Jikang Shi; Zhaorui Cheng; Shuang Qiu; Heran Cui; Yulu Gu; Qian Zhao; Yaxuan Ren; He Zhang; Helin Sun; Yunkai Liu; Yong Li; Yichun Qiao; Yueyang Hu; Yawen Liu; Yi Cheng
Journal:  Lipids Health Dis       Date:  2020-06-13       Impact factor: 3.876

4.  Association between PNPLA2 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in a Chinese Han Population with Type 2 Diabetes.

Authors:  Hailing Zhao; Haojun Zhang; Yan Wang; Tingting Zhao; Meihua Yan; Xi Dong; Qian Wang; Jialin Li; Liang Ma; Ping Li
Journal:  J Diabetes Res       Date:  2020-06-30       Impact factor: 4.011

5.  A systematic integrative approach reveals novel microRNAs in diabetic nephropathy.

Authors:  Farnoush Kiyanpour; Maryam Abedi; Yousof Gheisari
Journal:  J Res Med Sci       Date:  2020-01-20       Impact factor: 1.852

6.  The single nucleotide polymorphism rs11643718 in SLC12A3 is associated with the development of diabetic kidney disease in Chinese people with type 2 diabetes.

Authors:  J-F Yang; X-F Xiong; Y Xiao; L Wei; L Li; M Yang; Y-C Han; H Zhao; C-R Li; N Jiang; S Xiong; L-F Zeng; Z-G Zhou; S-P Liu; N-S Wang; Y Fan; L Sun
Journal:  Diabet Med       Date:  2020-07-23       Impact factor: 4.359

7.  The Association of UNC13B Gene Polymorphisms and Diabetic Kidney Disease in a Chinese Han Population.

Authors:  Ya Wang; Jie Tan; Dan Liu; Yameng Yang; Hongyan Wu
Journal:  Med Sci Monit       Date:  2019-11-12

Review 8.  Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes.

Authors:  Vjera Ninčević; Tea Omanović Kolarić; Hrvoje Roguljić; Tomislav Kizivat; Martina Smolić; Ines Bilić Ćurčić
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

Review 9.  Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection.

Authors:  Yi-Chou Hou; Cai-Mei Zheng; Tzung-Hai Yen; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

Review 10.  Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.

Authors:  Suyan Duan; Fang Lu; Dandan Song; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.